
Ozempic, Wegovy Linked to Higher Risk of Rare Form of Vision Loss, Study Suggests
People who use diabetes drugs Ozempic or Wegovy may be at increased risk of developing a rare form of blindness, according to a new study published on July 3 in the medical journal JAMA Ophthalmology. In the study, researchers looked at whether the risk of non-arteritic anterior ischemic optic neuropathy (NAION) is increased in Type 2 diabetics or overweight or obese patients who are prescribed semaglutide—the generic name for Ozempic and Wegovy. The researchers, at Brigham and Women’s Hospital, the Chan School of Public Health, and Massachusetts Eye and Ear, at Harvard Medical School in Boston, analyzed a cohort study of 16,827 patients in the Boston area—none of whom had the eye condition—from between Dec. 1, 2017, through Nov. 30, 2023....
